4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0000950170-24-131250
Chief Financial Officer bought 12,829 shares at an average $3.82 ($48,974)
From the SEC's structured data for this filing
Trades in this filing
Hunt Jonathan Robert · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-25 | Purchase : show line 1 in the form | +400 | $3.55 | $1,420 | 36,371 | D |
| 2024-11-25 | Purchase : show line 2 in the form | +29 | $3.94 | $114 | 36,400 | D |
| 2024-11-25 | Purchase : show line 3 in the form | +2,400 | $3.60 | $8,640 | 38,800 | D |
| 2024-11-25 | Purchase : show line 4 in the form | +10,000 | $3.88 | $38,800 | 48,800 | D |
| Open-market purchases · 12,829 sh · avg $3.82 · $48,974 | ||||||
Loading xslF345X05/ownership.xml…